The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response

doi:10.1093/jncics/pky072

Editorial

. 2018 Nov;2(4):pky072.

doi: 10.1093/jncics/pky072. Epub 2019 Jan 29.

The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response

Maeve Mullooly, Gretchen L Gierach

PMID: 30746510
PMCID: PMC6357814
DOI: 10.1093/jncics/pky072

Editorial

The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response

Maeve Mullooly et al. JNCI Cancer Spectr. 2018 Nov.

. 2018 Nov;2(4):pky072.

doi: 10.1093/jncics/pky072. Epub 2019 Jan 29.

Authors

Maeve Mullooly, Gretchen L Gierach

PMID: 30746510
PMCID: PMC6357814
DOI: 10.1093/jncics/pky072

No abstract available

PubMed Disclaimer

Comment in

Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.
Eriksson L, He W, Eriksson M, Humphreys K, Bergh J, Hall P, Czene K. Eriksson L, et al. JNCI Cancer Spectr. 2019 Jan 29;2(4):pky071. doi: 10.1093/jncics/pky071. eCollection 2018 Oct. JNCI Cancer Spectr. 2019. PMID: 31360886 Free PMC article.

Cited by

Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.
Mullooly M, Nyante SJ, Pfeiffer RM, Cora R, Butcher D, Sternberg L, Aiello Bowles EJ, Fan S, Figueroa JD, Weinmann S, Hoover RN, Brinton LA, Berrington de Gonzalez A, Glass A, Sherman ME, Gierach GL. Mullooly M, et al. J Clin Med. 2019 Nov 4;8(11):1868. doi: 10.3390/jcm8111868. J Clin Med. 2019. PMID: 31689948 Free PMC article.
Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography.
Gierach GL, Sak M, Fan S, Pfeiffer RM, Palakal M, Ramin C, Bey-Knight L, Simon MS, Gorski D, Ali H, Littrup P, Sherman ME, Duric N. Gierach GL, et al. J Clin Med. 2022 Feb 1;11(3):792. doi: 10.3390/jcm11030792. J Clin Med. 2022. PMID: 35160244 Free PMC article.
Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease.
Mullooly M, Fan S, Pfeiffer RM, Bowles EA, Duggan MA, Falk RT, Richert-Boe K, Glass AG, Kimes TM, Figueroa JD, Rohan TE, Abubakar M, Gierach GL. Mullooly M, et al. Breast Cancer Res. 2024 Mar 26;26(1):52. doi: 10.1186/s13058-024-01764-2. Breast Cancer Res. 2024. PMID: 38532516 Free PMC article.
Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J, Wang B, Zhao J, Mao Y, Liu J, Yang Y. Zhao J, et al. Thorac Cancer. 2020 Nov;11(11):3107-3116. doi: 10.1111/1759-7714.13611. Epub 2020 Sep 15. Thorac Cancer. 2020. PMID: 32930510 Free PMC article.
Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed.
Duric N, Sak M, Fan S, Pfeiffer RM, Littrup PJ, Simon MS, Gorski DH, Ali H, Purrington KS, Brem RF, Sherman ME, Gierach GL. Duric N, et al. J Clin Med. 2020 Jan 29;9(2):367. doi: 10.3390/jcm9020367. J Clin Med. 2020. PMID: 32013177 Free PMC article.

See all "Cited by" articles

References

1. Eriksson L, He W, Eriksson M, et al. Adjuvant therapy and mammographic density changes in women with breast cancer. JNCI Cancer Spectr. 2018;00(0):pky071. - PMC - PubMed
1. Mullooly M, Pfeiffer RM, Nyante SJ, et al. Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications. J Clin Oncol. 2016;34(18):2093–2097. - PMC - PubMed
1. Shawky MS, Martin H, Hugo HJ, et al. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies. Oncotarget. 2017;8(3):5578–5591. - PMC - PubMed
1. Li J, Humphreys K, Eriksson L, et al. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol. 2013;31(18):2249–2256. - PMC - PubMed
1. Murphy CC, Bartholomew LK, Carpentier MY, et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134(2):459–478. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

[1] Eriksson L, He W, Eriksson M, et al. Adjuvant therapy and mammographic density changes in women with breast cancer. JNCI Cancer Spectr. 2018;00(0):pky071. - PMC - PubMed

[2] Eriksson L, He W, Eriksson M, et al. Adjuvant therapy and mammographic density changes in women with breast cancer. JNCI Cancer Spectr. 2018;00(0):pky071. - PMC - PubMed

[3] Mullooly M, Pfeiffer RM, Nyante SJ, et al. Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications. J Clin Oncol. 2016;34(18):2093–2097. - PMC - PubMed

[4] Mullooly M, Pfeiffer RM, Nyante SJ, et al. Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications. J Clin Oncol. 2016;34(18):2093–2097. - PMC - PubMed

[5] Shawky MS, Martin H, Hugo HJ, et al. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies. Oncotarget. 2017;8(3):5578–5591. - PMC - PubMed

[6] Shawky MS, Martin H, Hugo HJ, et al. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies. Oncotarget. 2017;8(3):5578–5591. - PMC - PubMed

[7] Li J, Humphreys K, Eriksson L, et al. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol. 2013;31(18):2249–2256. - PMC - PubMed

[8] Li J, Humphreys K, Eriksson L, et al. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol. 2013;31(18):2249–2256. - PMC - PubMed

[9] Murphy CC, Bartholomew LK, Carpentier MY, et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134(2):459–478. - PMC - PubMed

[10] Murphy CC, Bartholomew LK, Carpentier MY, et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134(2):459–478. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response

The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response

Authors

Comment in

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources